Your browser doesn't support javascript.
loading
Integrative Mendelian randomization reveals the soluble receptor for advanced glycation end products as protective in relation to rheumatoid arthritis.
Lee, Gha Young; Yao, Chen; Hwang, Shih-Jen; Ma, Jiantao; Joehanes, Roby; Lee, Dong Heon; Ellison, R Curtis; Moore, Lynn L; Liu, Chunyu; Levy, Daniel.
Afiliación
  • Lee GY; Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Yao C; Framingham Heart Study, 73 Mt. Wayte Avenue, Framingham, MA, 01702, USA.
  • Hwang SJ; Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Ma J; Framingham Heart Study, 73 Mt. Wayte Avenue, Framingham, MA, 01702, USA.
  • Joehanes R; Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Lee DH; Framingham Heart Study, 73 Mt. Wayte Avenue, Framingham, MA, 01702, USA.
  • Ellison RC; Framingham Heart Study, 73 Mt. Wayte Avenue, Framingham, MA, 01702, USA.
  • Moore LL; School of Nutrition Science and Policy, Tufts University, Boston, USA.
  • Liu C; Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Levy D; Framingham Heart Study, 73 Mt. Wayte Avenue, Framingham, MA, 01702, USA.
Sci Rep ; 13(1): 8002, 2023 05 17.
Article en En | MEDLINE | ID: mdl-37198231

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Reumatoide / Enfermedades Cardiovasculares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Reumatoide / Enfermedades Cardiovasculares Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos